WNT16 / Protein Wnt-16 · Western blot design guide

Design a Western Blot for WNT16

Source-linked WNT16 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-WNT16 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for WNT16: expected band ~40.7 kDa, hero antibody A03606-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable WNT16 Western blot protocol sheet — expected band ~40.7 kDa, antibody A03606-1, controls and PMC citations. Open the full WNT16 WB guide →

WNT16 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~40.7 kDa
Gel 12–15% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Glycosylation-state controls
Gene-set association MSigDB Hallmark membership
Isoform 2 isoform(s)
Section 1

Source-Linked WNT16 Western Blot Protocol Options

The A03606-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateTarget-positive lysate and matched negative control (standard starting point)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA03606-1; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected WNT16 Western Blot Band Size?

WNT16 has a predicted 40.7 kDa precursor; signal-peptide cleavage, N-linked glycosylation, and isoforms may affect migration, but no empirical band is supplied.

What am I looking at on my blot?
Band near 40.7 kDaconsistent with the predicted WNT16 precursor, pending band-identity controls
Band above 40.7 kDacould reflect N-linked glycosylation at Asn143, Asn189, or Asn311; a visible shift is unproven
Band below 40.7 kDacould reflect cleavage of the signal peptide at residues 1–29
Several bands at different sizescould include Wnt-16a and Wnt-16b, though distinct migration is unproven
Little or no band in whole-cell lysateWNT16 may be found in the extracellular space or matrix
💡Expected WNT16 appearance40.7 kDa is the predicted WNT16 precursor mass; signal-peptide cleavage and N-linked glycosylation may alter migration, but no empirical band size is supplied, so confirm band identity with controls.
How each factor affects band size
UniProt predicted precursor mass40.7 kDa provides the full-length reference size, not a measured band
N-linked glycosylation at Asn143, Asn189, and Asn311may increase apparent size; no visible shift is established
Signal peptide at residues 1–29cleavage makes the mature protein smaller than the precursor
Wnt-16a and Wnt-16b isoformsmay differ in apparent size; their relative sizes are unknown
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateWNT16 is secreted and associated with extracellular space or matrixcheck conditioned medium or an extracellular matrix fraction alongside lysate
Band higher than expectedN-linked glycosylation is possible at three documented sitescompare matched samples before and after N-glycan removal and confirm band identity
Band lower than expectedsignal-peptide cleavage can reduce size relative to the precursorcheck antibody epitope coverage and confirm the band with WNT16 depletion
Broad smear instead of sharp bandvariable N-linked glycosylation is possible, but a smear is not establishedcompare matched samples before and after N-glycan removal
Multiple bandsWnt-16a and Wnt-16b are annotated isoforms, but separate bands are unprovenuse WNT16 depletion to identify specific bands
Weak or no signalsecreted WNT16 may be scarce in the tested cell fractiontest conditioned medium or extracellular matrix material with a positive control

Sample controls for WNT16 Western blot

🧪For positive controls for WNT16 in Western blot, you can use conditioned medium from a verified WNT16-expressing source; the supplied HPA data identify no positive tissue or cell.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: WNT16 is secreted, so conditioned medium may give a clearer signal than whole-cell lysate; HPA provides no tissue controls.

HPA tissue expression evidence for WNT16

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced WNT16 Western Blot Tips

Deeper troubleshooting and optimisation questions for WNT16, answered from its protein features.

How should WNT16 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could WNT16 isoforms account for different bands?
Isoforms · Two isoforms are listed: Wnt-16b and Wnt-16a. Wnt-16a has an alternative sequence at UniProt residues 1–32. Check which isoform the sample and antibody cover before assigning bands; the supplied features do not establish their apparent sizes.
Which WNT16 glycosylation sites matter when assessing bands?
PTM · UniProt lists N-linked sites at Asn143, Asn189, and Asn311. These are coordinates in the supplied UniProt sequence; check the numbering convention before comparing them with an antibody or paper. The site annotations alone do not prove a visible shift.
Does this guide establish induction of WNT16?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for WNT16?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A03606-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should WNT16 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Why might WNT16 migrate differently from its predicted 40.7 kDa?
Interpretation · The 40.7 kDa value is predicted. WNT16 has a signal peptide at residues 1–29 and three listed N-linked glycosylation sites. These features may affect the protein detected, but they do not establish an apparent band size or explain a particular mass difference.

UniProt annotates a signal peptide at residues 1–29 of the supplied sequence. Consider signal peptide processing when comparing a band with the 40.7 kDa predicted value, but do not assign a processed band size from this annotation alone. Wnt-16a has an alternative N-terminal sequence, so check isoform numbering.

WNT16 is annotated as secreted and located in the extracellular space and extracellular matrix. Consider those compartments when choosing samples and interpreting a weak signal in a cell lysate.

Use the same sample compartment across comparisons, since WNT16 is annotated in the extracellular space and extracellular matrix. Define which bands you quantify consistently; two isoforms and three N-linked glycosylation sites are listed, but their apparent band patterns are not supplied.

Check whether the bands are consistent with the two listed isoforms, the alternative N-terminal sequence, signal peptide processing, or the three annotated N-linked sites. The features do not identify any particular observed band, so they cannot confirm its identity or explain its size on their own.
Boster reagents

WNT16 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data WNT16 Antibody (C-term) western blot analysis in CEM cell line lysates (35ug/lane). This demonstrates the WNT16 antibody detected the WNT16 protein (arrow).
Anti-WNT16 Antibody (C-term)
Cat # A03606-1
Real WB data Western blot analysis of WNT16 using anti-WNT16 antibody (M03606). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human SH-SY5Y whole cell lysates, Lane 2: human U251 whole cell lysates, Lane 3: rat kidney tissue lysates, Lane 4: mouse kidney tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-WNT16 antigen affinity purified monoclonal antibody (M03606) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for WNT16 at approximately 41 kDa. The expected band size for WNT16 is at 41 kDa.
Anti-Wnt16 Rabbit Monoclonal Antibody
Cat # M03606

Two the supplier anti-WNT16 antibodies have supplied Western blot images: A03606-1 in CEM cell lysate and M03606 in human SH-SY5Y and U251 cell lysates plus rat and mouse kidney lysates. No publication evidence is supplied.

Which to pick: For human CEM lysate, A03606-1 has a WB image. M03606 lists human, mouse, and rat reactivity; its WB image includes samples from all three species and reports an approximately 41 kDa band.

Source: BosterBio WNT16 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.